Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site. # Alpheus Medical Pioneering Sonodynamic Therapy for Brain Cancer ## Sitemaps - [XML Sitemap](https://alpheusmedical.com/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [Brain Tumor Investment Fund Highlights Alpheus in Portfolio Spotlight](https://alpheusmedical.com/news/brain-tumor-investment-fund-highlights-alpheus-in-portfolio-spotlight/) - [Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma](https://alpheusmedical.com/news/alpheus-medical-initiates-phase-2b-trial-of-investigational-therapy-for-newly-diagnosed-glioblastoma/) - [Alpheus Medical Raises $52M in Series B Round to Advance Groundbreaking Glioblastoma Therapy.](https://alpheusmedical.com/news/alpheus-medical-raises-52m-in-series-b-round-to-advance-groundbreaking-glioblastoma-therapy/) - Funding will support a randomized Phase 2B study of the novel sonodynamic therapy in patients with newly diagnosed glioblastoma. - [Alpheus Medical Closes $16m in Series a Financing for Novel Glioma Brain Cancer Treatment](https://alpheusmedical.com/news/alpheus-medical-closes-16m-in-series-a-financing-for-novel-glioma-brain-cancer-treatment/) - Funds to support first-in-human (FIH) clinical trial of the company’s proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas - [Alpheus Medical Announces Formation of World-Class Scientific Advisory Board (SAB) to Support Development of Novel Treatment for Brain Cancer](https://alpheusmedical.com/news/alpheus-medical-announces-formation-of-world-class-scientific-advisory-board-sab-to-support-development-of-novel-treatment-for-brain-cancer/) - SAB to provide meaningful guidance as the company begins a first-in-human (FIH) clinical trial of their proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas - [Alpheus Medical Treats First Patients in First-In-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer Treatment](https://alpheusmedical.com/news/alpheus-medical-treats-first-patients-in-first-in-human-clinical-trial-for-novel-high-grade-glioma-brain-cancer-treatment/) - Milestone arrives as the company closes a $14 million follow-on Series A financing round to expand the clinical program for high-grade gliomas, including glioblastomas, and pursue additional indications. - [FDA Grants Alpheus Medical Orphan Drug and Fast Track Designations for Novel Sonodynamic Therapy for Brain Cancer](https://alpheusmedical.com/news/fda-grants-alpheus-medical-orphan-drug-and-fast-track-designations-for-novel-sonodynamic-therapy-for-brain-cancer/) - The company is currently enrolling patients in a multi-center Phase 1 clinical trial for the treatment of recurrent glioblastoma (GBM) - [Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas](https://alpheusmedical.com/news/alpheus-medical-announces-positive-phase-1-2-trial-results-for-the-treatment-of-recurrent-high-grade-gliomas/) - The results from their first-in-human study demonstrated that median overall survival was doubled and progression-free survival improved 3-fold. The Company’s novel sonodynamic therapy platform selectively targets and destroys cancer cells in the brain while preserving healthy tissue. - [Alpheus Medical Publishes Promising Early Clinical Results of Sonodynamic Therapy for the Treatment of Newly Diagnosed Glioblastomas](https://alpheusmedical.com/news/alpheus-medical-publishes-promising-early-clinical-results-of-sonodynamic-therapy-for-the-treatment-of-newly-diagnosed-glioblastomas/) - “SDT’s ability to selectively induce immediate tumor cell death while sparing healthy brain tissue is unprecedented.” ## Pages - [Home](https://alpheusmedical.com/) - Alpheus is advancing a new therapeutic approach designed to improve outcomes while reducing treatment burden for patients and families. - [Patients & Resources](https://alpheusmedical.com/patients-and-resources/) - Learn more about the Alpheus Brain Cancer Study and find additional information and resources for patients. - [Program Overview](https://alpheusmedical.com/program-overview/) - Learn more about Alpheus Medical's platform, how the therapy works, and the challenges of Glioblastoma (GBM). - [About Us](https://alpheusmedical.com/about-us/) - Alpheus Medical is developing an investigational therapy that pairs a tumor-accumulating drug with low-intensity ultrasound to achieve localized pharmacologic activation inside solid tumors. - [Footer](https://alpheusmedical.com/footer/) - [Privacy Policy](https://alpheusmedical.com/privacy-policy/) - Read and review Alpheus Medical's Privacy Policy - [HTML Sitemap](https://alpheusmedical.com/sitemap/) - [Terms of Use](https://alpheusmedical.com/terms-of-use/) - Read and review the Alpheus Medical Terms of Use - [Company News](https://alpheusmedical.com/news/) - Keep up to date on recent news from Alpheus Medical. ## Team - [Walter Stummer, MD](https://alpheusmedical.com/leadership/walter-stummer-md/) - [Juan-Pablo Mas](https://alpheusmedical.com/leadership/juan-pablo-mas/) - [John Johnson](https://alpheusmedical.com/leadership/john-johnson/) - [Robert Stein, MD, Ph.D](https://alpheusmedical.com/leadership/robert-stein-md/) - [Nick Ellens, Ph.D](https://alpheusmedical.com/leadership/nick-ellens/) - Vice President, Research & Development - [Klaus Veitinger, MD, Ph.D](https://alpheusmedical.com/leadership/klaus-veitinger/) - Executive Chairman of the Board - [David Reardon, MD](https://alpheusmedical.com/leadership/david-reardon-md/) - Professor, Medicine, Harvard Medical School; Clinical Director, Center for Neuro-Oncology, Medical Oncology, Dana-Farber Cancer Institute. - [Roger Stupp, MD](https://alpheusmedical.com/leadership/roger-stupp/) - Chief of Neuro-oncology, Professor of Neurological Surgery, Medicine and Neurology, Feinberg School of Medicine at Northwestern University. - [Peter Thomson, MD](https://alpheusmedical.com/leadership/peter-thomson-md/) - OrbiMed Advisors - [Vijay Agarwal, MD](https://alpheusmedical.com/leadership/vijay-agarwal/) - Founder, President and CEO - [Imran Eba
](https://alpheusmedical.com/leadership/imran-eba/) - Chief Financial Officer - [Jeremy Ling](https://alpheusmedical.com/leadership/jeremy-ling/) - Chief Technology Officer - [Ann-Marie Hulstine
](https://alpheusmedical.com/leadership/ann-marie-hulstine/) - Vice President, Clinical Operations - [Mike Preigh, Ph.D](https://alpheusmedical.com/leadership/mike-preigh/) - Vice President, Chemistry, Manufacturing & Controls (CMC) ## Categories - [News](https://alpheusmedical.com/category/news/) - [new-tab](https://alpheusmedical.com/category/new-tab/) ## Portfolio Categories - [Leadership](https://alpheusmedical.com/leadership/leadership/) - [Board of Directors](https://alpheusmedical.com/leadership/board-of-directors/) - [Scientific Advisory Board](https://alpheusmedical.com/leadership/scientific-advisory-board/)